Bioforce Nanosciences Holdings Stock Buy Hold or Sell Recommendation
| BFNH Stock | USD 1.09 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding BioForce Nanosciences Holdings is 'Strong Sell'. The recommendation algorithm takes into account all of BioForce Nanosciences' available fundamental, technical, and predictive indicators you will find on this site.
Check out BioForce Nanosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as BioForce and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards BioForce Nanosciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
BioForce |
Execute BioForce Nanosciences Buy or Sell Advice
The BioForce recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BioForce Nanosciences Holdings. Macroaxis does not own or have any residual interests in BioForce Nanosciences Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BioForce Nanosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
BioForce Nanosciences Trading Alerts and Improvement Suggestions
| BioForce Nanosciences generated a negative expected return over the last 90 days | |
| BioForce Nanosciences has high historical volatility and very poor performance | |
| BioForce Nanosciences has some characteristics of a very speculative penny stock | |
| BioForce Nanosciences Holdings currently holds 156.87 K in liabilities with Debt to Equity (D/E) ratio of 4.61, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BioForce Nanosciences has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist BioForce Nanosciences until it has trouble settling it off, either with new capital or with free cash flow. So, BioForce Nanosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioForce Nanosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioForce to invest in growth at high rates of return. When we think about BioForce Nanosciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (501.95 K) with profit before overhead, payroll, taxes, and interest of 4.36 K. | |
| BioForce Nanosciences Holdings currently holds about 9.23 K in cash with (77.77 K) of positive cash flow from operations. | |
| Roughly 82.0% of BioForce Nanosciences shares are held by company insiders |
BioForce Nanosciences Returns Distribution Density
The distribution of BioForce Nanosciences' historical returns is an attempt to chart the uncertainty of BioForce Nanosciences' future price movements. The chart of the probability distribution of BioForce Nanosciences daily returns describes the distribution of returns around its average expected value. We use BioForce Nanosciences Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BioForce Nanosciences returns is essential to provide solid investment advice for BioForce Nanosciences.
| Mean Return | -0.01 | Value At Risk | -13.64 | Potential Upside | 5.00 | Standard Deviation | 7.84 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BioForce Nanosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BioForce Nanosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioForce Nanosciences or Consumer Defensive sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioForce Nanosciences' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioForce pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.27 | |
β | Beta against Dow Jones | 1.91 | |
σ | Overall volatility | 7.96 | |
Ir | Information ratio | -0.02 |
BioForce Nanosciences Volatility Alert
BioForce Nanosciences Holdings is displaying above-average volatility over the selected time horizon. BioForce Nanosciences Holdings is a potential penny stock. Although BioForce Nanosciences may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in BioForce Nanosciences Holdings. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on BioForce instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.BioForce Nanosciences Fundamentals Vs Peers
Comparing BioForce Nanosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioForce Nanosciences' direct or indirect competition across all of the common fundamentals between BioForce Nanosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioForce Nanosciences or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of BioForce Nanosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing BioForce Nanosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BioForce Nanosciences to competition |
| Fundamentals | BioForce Nanosciences | Peer Average |
| Return On Asset | -21.84 | -0.14 |
| Current Valuation | 50.2 M | 16.62 B |
| Shares Outstanding | 29.27 M | 571.82 M |
| Shares Owned By Insiders | 82.29 % | 10.09 % |
| Price To Earning | (1.52) X | 28.72 X |
| Price To Book | 866.24 X | 9.51 X |
| Price To Sales | 3,841 X | 11.42 X |
| Gross Profit | 4.36 K | 27.38 B |
| EBITDA | (501.95 K) | 3.9 B |
| Net Income | (501.95 K) | 570.98 M |
| Cash And Equivalents | 9.23 K | 2.7 B |
| Total Debt | 156.87 K | 5.32 B |
| Debt To Equity | 4.61 % | 48.70 % |
| Current Ratio | 0.01 X | 2.16 X |
| Book Value Per Share | (0.04) X | 1.93 K |
| Cash Flow From Operations | (77.77 K) | 971.22 M |
| Earnings Per Share | (0.02) X | 3.12 X |
| Target Price | 0.25 | |
| Number Of Employees | 2 | 18.84 K |
| Beta | -1.93 | -0.15 |
| Market Capitalization | 72.74 M | 19.03 B |
| Total Asset | 11.14 K | 29.47 B |
| Retained Earnings | (21 K) | 9.33 B |
| Working Capital | 14 K | 1.48 B |
| Current Asset | 15 K | 9.34 B |
| Current Liabilities | 1 K | 7.9 B |
| Net Asset | 11.14 K |
BioForce Nanosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BioForce . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About BioForce Nanosciences Buy or Sell Advice
When is the right time to buy or sell BioForce Nanosciences Holdings? Buying financial instruments such as BioForce Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having BioForce Nanosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marketing Thematic Idea Now
Marketing
Companies providing marketing and public relation (PR) services as well as news and media distribution. The Marketing theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marketing Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BioForce Pink Sheet
BioForce Nanosciences financial ratios help investors to determine whether BioForce Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioForce with respect to the benefits of owning BioForce Nanosciences security.